Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study
Background: Conventionally, letrozole for ovulation induction (OI) in polycystic ovary syndrome (PCOS) is started at a dose of 2.5 mg, which is gradually escalated depending on the follicular response. The minimum dose required for follicular response for a particular patient is yet to be determined...
Saved in:
Main Authors: | Pratyasha Peepal, Padmalaya Thakur, Anubhuti Patel, Jyotiranjan Sahoo, Sujata Pradhan, Manisha Sahu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
Series: | Journal of Human Reproductive Sciences |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jhrs.jhrs_72_25 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PECULIARITIES OF STIMULATION OF OVULATION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME OF DIERENT AGE
by: M. P. Mironova, et al.
Published: (2016-06-01) -
Ameliorative effects of Sesamum Indicum aqueous extract on Letrozole-induced polycystic ovary syndrome in adult female rats and formulation of sesame syrup
by: Zeynab Khosrowpour, et al.
Published: (2025-07-01) -
Individualisation of cities as one of the factors of preserving human capital
by: E. A. Zakharchuk, et al.
Published: (2022-02-01) -
Comparative Analysis of Letrozole and Estradiol Valerate PCOS Models: Reproductive and Metabolic Outcomes with and Without High-Fat Diet
by: Xóchitl Acuña Escalona, et al.
Published: (2025-05-01) -
Angioneurotic edema of metastatic breast cancer patient associated with letrozole
by: Yasemin Bakkal Temi, et al.
Published: (2017-12-01)